Natural Products and Synthetic Analogs as a Source of Antitumor Drugs

Cancer is a heterogeneous disease and one of the major issues of health concern, especially for the public health system globally. Nature is a source of anticancer drugs with abundant pool of diverse chemicals and pharmacologically active compounds. In recent decade, some natural products and synthetic analogs have been investigated for the cancer treatment. This article presents the utilization of natural products as a source of antitumor drugs.

[1]  J. Price.  Oral Cavity Squamous Cell Carcinoma , 2020, Definitions.

[2]  E. Becer,et al.  The Effect of Resveratrol and Quercetin on Epithelial-Mesenchymal Transition in Pancreatic Cancer Stem Cell , 2020, Nutrition and cancer.

[3]  E. Karimi,et al.  Galbanic acid: Induced antiproliferation in estrogen receptor‐negative breast cancer cells and enhanced cellular redox state in the human dermal fibroblasts , 2019, Journal of biochemical and molecular toxicology.

[4]  A. Cecchini,et al.  Citral prevents UVB-induced skin carcinogenesis in hairless mice. , 2019, Journal of photochemistry and photobiology. B, Biology.

[5]  B. Aggarwal,et al.  Is curcumin bioavailability a problem in humans: lessons from clinical trials , 2019, Expert opinion on drug metabolism & toxicology.

[6]  Weidong Zhang,et al.  Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming , 2019, Journal of experimental & clinical cancer research : CR.

[7]  M. Martorell,et al.  Flavonoids nanoparticles in cancer: Treatment, prevention and clinical prospects. , 2019, Seminars in cancer biology.

[8]  N. Yusuf,et al.  A Novel Marine Natural Product Derived Pyrroloiminoquinone with Potent Activity against Skin Cancer Cells , 2019, Marine drugs.

[9]  N. Xu,et al.  The natural compound neobractatin inhibits tumor metastasis by upregulating the RNA-binding-protein MBNL2 , 2019, Cell Death & Disease.

[10]  B. Salehi,et al.  Phytochemicals in Prostate Cancer: From Bioactive Molecules to Upcoming Therapeutic Agents , 2019, Nutrients.

[11]  M. M. Jacobs.  Inhibition of Colon Carcinogenesis* , 2019, Experimental Colon Carcinogenesis.

[12]  M. Shakibaei,et al.  Cancer drug development: The missing links , 2019, Experimental biology and medicine.

[13]  B. Salehi,et al.  Synergistic Effects of Plant Derivatives and Conventional Chemotherapeutic Agents: An Update on the Cancer Perspective , 2019, Medicina.

[14]  Kelly E McCann.  Advances in the use of PARP inhibitors for BRCA1/2-associated breast cancer: talazoparib. , 2019, Future oncology.

[15]  Guo-ping Ding,et al.  Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways , 2019, Cell Death & Disease.

[16]  Sudeep Gupta,et al.  Targeted therapy in cervical cancer , 2019, ESMO Open.

[17]  F. Morabito,et al.  Lenalidomide for the treatment of mantle cell lymphoma , 2019, Expert opinion on pharmacotherapy.

[18]  M. Samatha,et al.  Effect of amygdalin on oral cancer cell line: An in vitro study , 2019, Journal of oral and maxillofacial pathology : JOMFP.

[19]  World Cancer Research Fund International , 2018, The Grants Register 2019.

[20]  M. Murata.  Inflammation and cancer , 2018, Environmental Health and Preventive Medicine.

[21]  Kemal M. Taskin,et al.  GR24, a synthetic analog of Strigolactones, alleviates inflammation and promotes Nrf2 cytoprotective response: In vitro and in silico evidences , 2018, Comput. Biol. Chem..

[22]  L. Frati,et al.  Effects of aloe emodin on U87MG glioblastoma cell growth: In vitro and in vivo study , 2018, Environmental toxicology.

[23]  W. Dong,et al.  Aloe-Emodin Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Colorectal Cancer Cells , 2018, Medical science monitor : international medical journal of experimental and clinical research.

[24]  Seda Savranoglu Kulabas,et al.  Ameliorative potential of Lavandula stoechas in metabolic syndrome via multitarget interactions. , 2018, Journal of ethnopharmacology.

[25]  Hua Li,et al.  The dietary compound luteolin inhibits pancreatic cancer growth by targeting BCL-2. , 2018, Food & function.

[26]  Luma G. Magalhães,et al.  Recent Advances and Perspectives in Cancer Drug Design. , 2018, Anais da Academia Brasileira de Ciencias.

[27]  C. Lovly,et al.  Mechanisms of receptor tyrosine kinase activation in cancer , 2018, Molecular Cancer.

[28]  Dhiraj Kumar,et al.  Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges , 2018, Molecular Cancer.

[29]  Vaibhav Jadhav,et al.  Arsenic trioxide: insights into its evolution to an anticancer agent , 2018, JBIC Journal of Biological Inorganic Chemistry.

[30]  H. Yalcin,et al.  Elaeagnus angustifolia Plant Extract Inhibits Angiogenesis and Downgrades Cell Invasion of Human Oral Cancer Cells via Erk1/Erk2 Inactivation , 2018, Nutrition and cancer.

[31]  T. Doi,et al.  Safety, pharmacokinetic, and pharmacodynamics of erdafitinib, a pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor, in patients with advanced or refractory solid tumors , 2018, Investigational New Drugs.

[32]  J. Ruda-Kucerova,et al.  Anticancer Activity of Artemisinin and its Derivatives. , 2017, Anticancer research.

[33]  W. Cho.  Molecular Connections of Aging and Cancer , 2017, Aging and disease.

[34]  Seda Savranoglu Kulabas,et al.  Aryl benzofuran derivatives from the stem bark of Calpocalyx dinklagei attenuate inflammation. , 2017, Phytochemistry.

[35]  Hyunggee Kim,et al.  BRM270, a Compound from Natural Plant Extracts, Inhibits Glioblastoma Stem Cell Properties and Glioblastoma Recurrence. , 2017, Journal of medicinal food.

[36]  Sung-Dae Cho,et al.  Nitidine chloride acts as an apoptosis inducer in human oral cancer cells and a nude mouse xenograft model via inhibition of STAT3 , 2017, Oncotarget.

[37]  E. Walter,et al.  The life and work of Rudolf Virchow 1821–1902: “Cell theory, thrombosis and the sausage duel” , 2017, Journal of the Intensive Care Society.

[38]  G. Cantore,et al.  Effects of hispolon on glioblastoma cell growth , 2017, Environmental toxicology.

[39]  M. Mojović,et al.  Antiradical activity of delphinidin, pelargonidin and malvin towards hydroxyl and nitric oxide radicals: The energy requirements calculations as a prediction of the possible antiradical mechanisms. , 2017, Food chemistry.

[40]  A. Ha,et al.  Anti-inflammatory effect of lycopene in SW480 human colorectal cancer cells , 2017, Nutrition research and practice.

[41]  Zuben E. Sauna,et al.  Recent advances in (therapeutic protein) drug development , 2017, F1000Research.

[42]  V. Tešević,et al.  Stictic acid inhibits cell growth of human colon adenocarcinoma HT-29 cells , 2017 .

[43]  S. Chou,et al.  Cinnamomum cassia essential oil and its major constituent cinnamaldehyde induced cell cycle arrest and apoptosis in human oral squamous cell carcinoma HSC‐3 cells , 2017, Environmental toxicology.

[44]  A. Mostafavi,et al.  Cytotoxic Effect of Thymus caramanicus Jalas on Human Oral Epidermoid Carcinoma KB Cells. , 2017, Brazilian dental journal.

[45]  S. Ghosh.  Giovanni Battista Morgagni (1682–1771): father of pathologic anatomy and pioneer of modern medicine , 2017, Anatomical Science International.

[46]  Z. An,et al.  Antibody-drug conjugates: recent advances in conjugation and linker chemistries , 2016, Protein & Cell.

[47]  Ignace Vergote,et al.  Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer. , 2016, The New England journal of medicine.

[48]  A. Bishayee,et al.  Bioactive natural products in cancer prevention and therapy: Progress and promise. , 2016, Seminars in cancer biology.

[49]  T. Curiel,et al.  Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[50]  A. Markham.  Atezolizumab: First Global Approval , 2016, Drugs.

[51]  A. Sood,et al.  Evaluation of rucaparib and companion diagnostics in the PARP inhibitor landscape for recurrent ovarian cancer therapy. , 2016, Future oncology.

[52]  Christopher Ty Williams.  Food and Drug Administration Drug Approval Process: A History and Overview. , 2016, The Nursing clinics of North America.

[53]  D. Newman,et al.  Drugs and Drug Candidates from Marine Sources: An Assessment of the Current “State of Play” , 2016, Planta Medica.

[54]  D. Newman,et al.  Natural Products as Sources of New Drugs from 1981 to 2014. , 2016, Journal of natural products.

[55]  Nikolaos Diamantis,et al.  Antibody-drug conjugates—an emerging class of cancer treatment , 2016, British Journal of Cancer.

[56]  A. Mitra,et al.  Novel delivery approaches for cancer therapeutics. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[57]  J. Brody,et al.  In situ vaccination: Cancer immunotherapy both personalized and off‐the‐shelf , 2015, Molecular oncology.

[58]  D. Nayak,et al.  Biologically synthesised silver nanoparticles from three diverse family of plant extracts and their anticancer activity against epidermoid A431 carcinoma. , 2015, Journal of colloid and interface science.

[59]  J. Patel,et al.  Cellular Effect of Curcumin and Citral Combination on Breast Cancer Cells: Induction of Apoptosis and Cell Cycle Arrest , 2015, Journal of breast cancer.

[60]  F. Balkwill,et al.  Inflammation and cancer: advances and new agents , 2015, Nature Reviews Clinical Oncology.

[61]  Huanyu Chen,et al.  FDA Approval Summary: Ramucirumab for Gastric Cancer , 2015, Clinical Cancer Research.

[62]  J. Wolchok,et al.  Clinical Activity of Ipilimumab in Acral Melanoma: A Retrospective Review. , 2015, The oncologist.

[63]  G. Sethi,et al.  Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy , 2015, Experimental biology and medicine.

[64]  F. Izzo,et al.  Dissecting the Role of Curcumin in Tumour Growth and Angiogenesis in Mouse Model of Human Breast Cancer , 2015, BioMed research international.

[65]  L. Scott.  Lenvatinib: First Global Approval , 2015, Drugs.

[66]  Y. Mechref,et al.  Cytotoxic saponin poliusaposide from Teucrium polium , 2015 .

[67]  C. Avendaño,et al.  Medicinal chemistry of anticancer drugs , 2015 .

[68]  M. Loh,et al.  Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: results from Children's Oncology Group Study AALL07P4. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[69]  M. Kinch,et al.  An analysis of FDA-approved drugs for oncology. , 2014, Drug discovery today.

[70]  R. Poole.  Pembrolizumab: First Global Approval , 2014, Drugs.

[71]  R. Wu,et al.  Curcumin Modulates miR‐19/PTEN/AKT/p53 Axis to Suppress Bisphenol A‐induced MCF‐7 Breast Cancer Cell Proliferation , 2014, Phytotherapy research : PTR.

[72]  V. Kojić,et al.  An insight into the cytotoxic activity of phytol at in vitro conditions , 2014, Natural product research.

[73]  Z. Wang,et al.  Apoptotic effect of genistein on human colon cancer cells via inhibiting the nuclear factor-kappa B (NF-κB) pathway , 2014, Tumor Biology.

[74]  A. Paci,et al.  Review of therapeutic drug monitoring of anticancer drugs part two--targeted therapies. , 2014, European journal of cancer.

[75]  A. Mantha,et al.  Essential Oils and Their Constituents as Anticancer Agents: A Mechanistic View , 2014, BioMed research international.

[76]  Teresa Bento,et al.  Aging and DNA damage in humans: a meta-analysis study , 2014, Aging.

[77]  Zhidong Lv,et al.  Curcumin induces apoptosis in breast cancer cells and inhibits tumor growth in vitro and in vivo. , 2014, International journal of clinical and experimental pathology.

[78]  Qian Zhao,et al.  Cancer wars: natural products strike back , 2014, Front. Chem..

[79]  M. Cascio,et al.  Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol. , 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[80]  David J. Newman,et al.  New horizons for old drugs and drug leads. , 2014, Journal of natural products.

[81]  O. Firuzi,et al.  Essential Oil Composition and Cytotoxic Activity of Libanotis transcaucasica Schischk. from Iran , 2014 .

[82]  Q. Hu,et al.  Ganoderma lucidum polysaccharides target a Fas/caspase dependent pathway to induce apoptosis in human colon cancer cells. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[83]  X. Zhong,et al.  EGCG inhibits properties of glioma stem-like cells and synergizes with temozolomide through downregulation of P-glycoprotein inhibition , 2014, Journal of Neuro-Oncology.

[84]  Jinming Gao,et al.  Review of poly (ADP-ribose) polymerase (PARP) mechanisms of action and rationale for targeting in cancer and other diseases. , 2014, Critical reviews in eukaryotic gene expression.

[85]  A. Herráez,et al.  Apoptosis induced by paclitaxel via Bcl-2, Bax and caspases 3 and 9 activation in NB4 human leukaemia cells is not modulated by ERK inhibition. , 2013, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[86]  Sung-Min Moon,et al.  Anticancer activity of Saussurea lappa extract by apoptotic pathway in KB human oral cancer cells , 2013, Pharmaceutical biology.

[87]  Avijit Paul,et al.  Apigenin, a bioactive flavonoid from Lycopodium clavatum, stimulates nucleotide excision repair genes to protect skin keratinocytes from ultraviolet B-induced reactive oxygen species and DNA damage. , 2013, Journal of acupuncture and meridian studies.

[88]  Daniel J. Sargent,et al.  Drug rechallenge and treatment beyond progression—implications for drug resistance , 2013, Nature Reviews Clinical Oncology.

[89]  K. Singletary,et al.  Curcumin binds tubulin, induces mitotic catastrophe, and impedes normal endothelial cell proliferation. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[90]  Y. Lim,et al.  In Vitro Cytotoxic, Antioxidant, and Antimicrobial Activities of Mesua beccariana (Baill.) Kosterm., Mesua ferrea Linn., and Mesua congestiflora Extracts , 2013, BioMed research international.

[91]  S. Yan.  An early history of human breast cancer: West meets East , 2013, Chinese journal of cancer.

[92]  L. Berkovich,et al.  Moringa Oleifera aqueous leaf extract down-regulates nuclear factor-kappaB and increases cytotoxic effect of chemotherapy in pancreatic cancer cells , 2013, BMC Complementary and Alternative Medicine.

[93]  W. Feng,et al.  Composition and potential anticancer activities of essential oils obtained from myrrh and frankincense , 2013, Oncology letters.

[94]  Palaniselvam Kuppusamy,et al.  A CASE STUDY- REGULATION AND FUNCTIONAL MECHANISMS OF CANCER CELLS AND CONTROL ITS ACTIVITY USING PLANTS AND THEIR DERIVATIVES , 2013 .

[95]  F. Leite,et al.  Evaluation of potential use of Cymbopogon sp. essential oils, (R)-citronellal and N-citronellylamine in cancer chemotherapy , 2013 .

[96]  W. Setzer,et al.  The Cytotoxic Activity of Annona muricata Leaf Oil from Badagary, Nigeria , 2013 .

[97]  Ruth F. Guillermo,et al.  Correction: Antineoplastic Effects of α-Santalol on Estrogen Receptor-Positive and Estrogen Receptor-Negative Breast Cancer Cells through Cell Cycle Arrest at G2/M Phase and Induction of Apoptosis , 2013, PLoS ONE.

[98]  J. Bouajila,et al.  Chemical composition and anticancer, antiinflammatory, antioxidant and antimalarial activities of leaves essential oil of Cedrelopsis grevei. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[99]  M. Lacy,et al.  Pomalidomide and its clinical potential for relapsed or refractory multiple myeloma: an update for the hematologist , 2013, Therapeutic advances in hematology.

[100]  E. I. Wang,et al.  Composition and in vitro Anticancer Activities of the Leaf Essential Oil of Neolitsea variabillima from Taiwan , 2013, Natural product communications.

[101]  L. Filipe,et al.  Oportunidades para inovação no tratamento da leishmaniose usando o potencial das plantas e produtos naturais como fontes de novos fármacos Potential for innovation in the treatment of leishmaniasis using plants and natural products as sources of new drugs , 2013 .

[102]  B. Aggarwal,et al.  Prevention and Treatment of Colorectal Cancer by Natural Agents from Mother Nature , 2013, Current Colorectal Cancer Reports.

[103]  N. Beaubier,et al.  Gastric cancer and trastuzumab: first biologic therapy in gastric cancer , 2013, Therapeutic advances in medical oncology.

[104]  A. Bode,et al.  Direct Targeting of MEK1/2 and RSK2 by Silybin Induces Cell-Cycle Arrest and Inhibits Melanoma Cell Growth , 2013, Cancer Prevention Research.

[105]  A. Matsuo,et al.  Chemical Constituents and Cytotoxic Evaluation of Essential Oils from Leaves of Porcelia macrocarpa (Annonaceae) , 2013, Natural product communications.

[106]  M. Steinmetz,et al.  Molecular Mechanism of Action of Microtubule-Stabilizing Anticancer Agents , 2013, Science.

[107]  Adriano D Andricopulo,et al.  Development of a natural products database from the biodiversity of Brazil. , 2013, Journal of natural products.

[108]  C. Chou,et al.  The mechanism of carvacrol-evoked [Ca2+]i rises and non-Ca2+-triggered cell death in OC2 human oral cancer cells. , 2013, Toxicology.

[109]  F. Anwar,et al.  Chemical composition and bioactivity studies of the essential oils from two Thymus species from the Pakistani flora , 2013 .

[110]  R. Maheshwari,et al.  Skin regenerative potentials of curcumin , 2013, BioFactors.

[111]  G. Fawzy,et al.  Chemical composition and biological evaluation of essential oils of Pulicaria jaubertii , 2013, Pharmacognosy magazine.

[112]  M. Choudhary,et al.  Immunomodulatory, cytotoxic and antileishmanial activity of phytoconstituents of Croton zambesicus , 2013 .

[113]  Wenjing Zhang,et al.  Galangin induces B16F10 melanoma cell apoptosis via mitochondrial pathway and sustained activation of p38 MAPK , 2013, Cytotechnology.

[114]  A. Georgakilas,et al.  Pleiotrophic effects of natural products in ROS-induced carcinogenesis: the role of plant-derived natural products in oral cancer chemoprevention. , 2012, Cancer letters.

[115]  J. Silverman,et al.  Marqibo® (vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine , 2012, Cancer Chemotherapy and Pharmacology.

[116]  K. Priyadarshini,et al.  Paclitaxel Against Cancer: A Short Review , 2012 .

[117]  F. Nedel,et al.  Antiproliferative activity of flower hexane extract obtained from Mentha spicata associated with Mentha rotundifolia against the MCF7, KB, and NIH/3T3 cell lines. , 2012, Journal of medicinal food.

[118]  A. Verma,et al.  Plumbagin, a plant derived natural agent inhibits the growth of pancreatic cancer cells in in vitro and in vivo via targeting EGFR, Stat3 and NF‐κB signaling pathways , 2012, International journal of cancer.

[119]  Jianwei Zhu,et al.  Mammalian cell protein expression for biopharmaceutical production. , 2012, Biotechnology advances.

[120]  I. Chu,et al.  Histone deacetylase 6 functions as a tumor suppressor by activating c‐Jun NH2‐terminal kinase‐mediated beclin 1‐dependent autophagic cell death in liver cancer , 2012, Hepatology.

[121]  G. Nightingale,et al.  Cabazitaxel (jevtana): a novel agent for metastatic castration-resistant prostate cancer. , 2012, P & T : a peer-reviewed journal for formulary management.

[122]  S. Liawruangrath,et al.  Chemical Constituents and Antioxidant and Biological Activities of the Essential Oil from Leaves of Solanum spirale , 2012, Natural product communications.

[123]  Ji-Young Kim,et al.  Essential Oil from Cryptomeria japonica Induces Apoptosis in Human Oral Epidermoid Carcinoma Cells via Mitochondrial Stress and Activation of Caspases , 2012, Molecules.

[124]  Qing-qing Wang,et al.  Piperine suppresses tumor growth and metastasis in vitro and in vivo in a 4T1 murine breast cancer model , 2012, Acta Pharmacologica Sinica.

[125]  Y. Kuo,et al.  The chalcone flavokawain B induces G2/M cell-cycle arrest and apoptosis in human oral carcinoma HSC-3 cells through the intracellular ROS generation and downregulation of the Akt/p38 MAPK signaling pathway. , 2012, Journal of agricultural and food chemistry.

[126]  David J Newman,et al.  Natural products as sources of new drugs over the 30 years from 1981 to 2010. , 2012, Journal of natural products.

[127]  Bradley S Moore,et al.  Lessons from the past and charting the future of marine natural products drug discovery and chemical biology. , 2012, Chemistry & biology.

[128]  T. Zvyagintseva,et al.  Anticancer activity in vitro of a fucoidan from the brown alga Fucus evanescens and its low-molecular fragments, structurally characterized by tandem mass-spectrometry. , 2012, Carbohydrate polymers.

[129]  Y. Chae,et al.  Pinus densiflora leaf essential oil induces apoptosis via ROS generation and activation of caspases in YD-8 human oral cancer cells , 2011, International journal of oncology.

[130]  S. Pavey,et al.  Defective Cell Cycle Checkpoints as Targets for Anti-Cancer Therapies , 2011, Front. Pharmacol..

[131]  V. Voynov,et al.  Therapeutic Proteins , 2012, Methods in Molecular Biology.

[132]  K. Fung,et al.  Boswellia sacra essential oil induces tumor cell-specific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cells , 2011, BMC complementary and alternative medicine.

[133]  K. Takeuchi,et al.  Receptor tyrosine kinases and targeted cancer therapeutics. , 2011, Biological & pharmaceutical bulletin.

[134]  A. Demain,et al.  Natural products for cancer chemotherapy , 2011, Microbial biotechnology.

[135]  T. Efferth,et al.  [Anticancer activity of Salvia officinalis essential oil against HNSCC cell line (UMSCC1)]. , 2011, HNO.

[136]  J. Imhoff,et al.  Bio-mining the microbial treasures of the ocean: new natural products. , 2011, Biotechnology advances.

[137]  H. Luesch,et al.  Marine natural products: a new wave of drugs? , 2011, Future medicinal chemistry.

[138]  H. Chung,et al.  Deoxyelephantopin from Elephantopus scaber L. induces cell-cycle arrest and apoptosis in the human nasopharyngeal cancer CNE cells. , 2011, Biochemical and biophysical research communications.

[139]  A. Jemal,et al.  Cancer statistics, 2011 , 2011, CA: a cancer journal for clinicians.

[140]  Xiuqiao Zhang,et al.  Anticancer, antioxidant and antimicrobial activities of the essential oil of Lycopus lucidus Turcz. var. hirtus Regel. , 2011, Food chemistry.

[141]  K. Watkin,et al.  Cytotoxicity Effects of Amoora rohituka and chittagonga on Breast and Pancreatic Cancer Cells , 2011, Evidence-based complementary and alternative medicine : eCAM.

[142]  Yan-tao Han,et al.  Effects of Ginkgo Biloba Extract EGb761 on Human Colon Adenocarcinoma Cells , 2011, Cellular Physiology and Biochemistry.

[143]  D. Kingston.  Modern natural products drug discovery and its relevance to biodiversity conservation. , 2011, Journal of natural products.

[144]  S. Chatterjee,et al.  Chemo-resistant melanoma sensitized by tamoxifen to low dose curcumin treatment through induction of apoptosis and autophagy , 2011, Cancer biology & therapy.

[145]  차인호,et al.  Chios mastic gum extracts as a potent antitumor agent that inhibits growth and induces apoptosis of oral cancer cells. , 2011 .

[146]  M. Mirjalili,et al.  Production of the anticancer drug taxol in Taxus baccata suspension cultures: A review , 2011 .

[147]  R. Shrivastava,et al.  Comparative anticancer potential of clove (Syzygium aromaticum)--an Indian spice--against cancer cell lines of various anatomical origin. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[148]  T. Efferth,et al.  Cytotoxicity of Thymus vulgaris essential oil towards human oral cavity squamous cell carcinoma. , 2011, Anticancer research.

[149]  Peter K. Plinkert,et al.  Chemical Composition and antiproliferative activity of essential oil from the leaves of a medicinal herb, Levisticum officinale, against UMSCC1 head and neck squamous carcinoma cells. , 2011, Anticancer research.

[150]  I. Cha,et al.  Chios mastic gum extracts as a potent antitumor agent that inhibits growth and induces apoptosis of oral cancer cells. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[151]  K. Kathiresan,et al.  Anticancer Drugs from Marine Flora: An Overview , 2011, Journal of oncology.

[152]  J. Blay,et al.  The dietary flavonoid apigenin enhances the activities of the anti-metastatic protein CD26 on human colon carcinoma cells , 2011, Clinical & Experimental Metastasis.

[153]  O. Sartor,et al.  Critical appraisal of cabazitaxel in the management of advanced prostate cancer , 2010, Clinical interventions in aging.

[154]  A. Georgakilas,et al.  The role of reactive oxygen species and oxidative stress in environmental carcinogenesis and biomarker development. , 2010, Chemico-biological interactions.

[155]  Hailing Yang,et al.  Paclitaxel-Dependent Cell Lines Reveal a Novel Drug Activity , 2010, Molecular Cancer Therapeutics.

[156]  J. Wesche,et al.  Roles of Fibroblast Growth Factor Receptors in Carcinogenesis , 2010, Molecular Cancer Research.

[157]  F. Anwar,et al.  Rosmarinus officinalis essential oil: antiproliferative, antioxidant and antibacterial activities , 2010, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].

[158]  D. Newman,et al.  Plant Natural Products in Anticancer Drug Discovery , 2010 .

[159]  D. Shin,et al.  Chemopreventive Potential of Natural Compounds in Head and Neck Cancer , 2010, Nutrition and cancer.

[160]  Wanyi Tai,et al.  The role of HER2 in cancer therapy and targeted drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[161]  D. Schadendorf,et al.  Improved survival with ipilimumab in patients with metastatic melanoma. , 2010, The New England journal of medicine.

[162]  H. Bendaoud,et al.  Chemical composition and anticancer and antioxidant activities of Schinus molle L. and Schinus terebinthifolius Raddi berries essential oils. , 2010, Journal of food science.

[163]  Erin E. Carlson,et al.  Natural products as chemical probes. , 2010, ACS chemical biology.

[164]  K. Arunasree.  Anti-proliferative effects of carvacrol on a human metastatic breast cancer cell line, MDA-MB 231. , 2010, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[165]  C. Terry,et al.  Triterpenes From Ganoderma Lucidum Induce Autophagy in Colon Cancer Through the Inhibition of p38 Mitogen-Activated Kinase (p38 MAPK) , 2010, Nutrition and cancer.

[166]  M. Büchler,et al.  Synergistic activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell characteristics. , 2010, Cancer research.

[167]  C. Bokemeyer,et al.  Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer , 2010, British journal of pharmacology.

[168]  T. Koyano,et al.  Terpenoids and a flavonoid glycoside from Acacia pennata leaves as hedgehog/GLI-mediated transcriptional inhibitors. , 2010, Journal of natural products.

[169]  T. Efferth,et al.  Activities of ten essential oils towards Propionibacterium acnes and PC-3, A-549 and MCF-7 cancer cells. , 2010, Molecules.

[170]  F. Afifi,et al.  Volatile oil composition and antiproliferative activity of Laurus nobilis, Origanum syriacum, Origanum vulgare, and Salvia triloba against human breast adenocarcinoma cells. , 2010, Nutrition research.

[171]  R. Mehta,et al.  Cancer Chemoprevention by Natural Products: How Far Have We Come? , 2010, Pharmaceutical Research.

[172]  Shilpa Puli,et al.  Effect of Combination Treatment of Rapamycin and Isoflavones on mTOR Pathway in Human Glioblastoma (U87) Cells , 2010, Neurochemical Research.

[173]  G. Yount,et al.  Cannabidiol Enhances the Inhibitory Effects of Δ9-Tetrahydrocannabinol on Human Glioblastoma Cell Proliferation and Survival , 2010, Molecular Cancer Therapeutics.

[174]  Yi-Zhong Cai,et al.  Natural Phenolic Compounds From Medicinal Herbs and Dietary Plants: Potential Use for Cancer Prevention , 2009, Nutrition and cancer.

[175]  Jesús Sanz,et al.  Cytotoxic activity of α-humulene and transcaryo- phyllene from Salvia officinalis in animal and human tumor cells , 2010 .

[176]  A. R. Fathilah,et al.  Antiproliferative activity of aqueous extract of Piper betle L. and Psidium guajava L. on KB and HeLa cell lines , 2010 .

[177]  J. L. La Clair,et al.  Natural product mode of action (MOA) studies: a link between natural and synthetic worlds. , 2010, Natural product reports.

[178]  S. Srivastava,et al.  BITC Sensitizes Pancreatic Adenocarcinomas to TRAIL-induced Apoptosis. , 2010, Cancer growth and metastasis.

[179]  Xian Jiang,et al.  Therapeutic effects of matrine on primary and metastatic breast cancer. , 2010, The American journal of Chinese medicine.

[180]  S. Nagini,et al.  Eugenol inhibits cell proliferation via NF-κB suppression in a rat model of gastric carcinogenesis induced by MNNG , 2011, Investigational New Drugs.

[181]  S. Nagini,et al.  The neem limonoids azadirachtin and nimbolide inhibit cell proliferation and induce apoptosis in an animal model of oral oncogenesis , 2010, Investigational New Drugs.

[182]  G. Dontu,et al.  Targeting breast stem cells with the cancer preventive compounds curcumin and piperine , 2010, Breast Cancer Research and Treatment.

[183]  H. Fan,et al.  An investigation of the ability of elemene to pass through the blood‐brain barrier and its effect on brain carcinomas , 2009 .

[184]  R. Nagler.  Saliva as a tool for oral cancer diagnosis and prognosis. , 2009, Oral oncology.

[185]  A. Sudhakar,et al.  History of Cancer, Ancient and Modern Treatment Methods. , 2009, Journal of cancer science & therapy.

[186]  Xianghui Ma,et al.  Anticancer drug discovery in the future: an evolutionary perspective. , 2009, Drug discovery today.

[187]  I. Cha,et al.  Essential oil of Artemisia capillaris induces apoptosis in KB cells via mitochondrial stress and caspase activation mediated by MAPK-stimulated signaling pathway. , 2009, Journal of food science.

[188]  R. Kelly,et al.  Axitinib—a selective inhibitor of the vascular endothelial growth factor (VEGF) receptor , 2009, Targeted Oncology.

[189]  B. Liagre,et al.  Citral inhibits cell proliferation and induces apoptosis and cell cycle arrest in MCF‐7 cells , 2009, Fundamental & clinical pharmacology.

[190]  P. Yu,et al.  Matrine suppresses breast cancer cell proliferation and invasion via VEGF-Akt-NF-κB signaling , 2009, Cytotechnology.

[191]  L. Costa-Lotufo,et al.  Antitumor Activity of the Essential Oil from the Leaves of Croton regelianus and Its Component Ascaridole , 2009, Chemistry & biodiversity.

[192]  J. Correia,et al.  Macromolecular interaction of halichondrin B analogues eribulin (E7389) and ER-076349 with tubulin by analytical ultracentrifugation. , 2009, Biochemistry.

[193]  Jeong-Chae Lee,et al.  MAPK activation is necessary to the apoptotic death of KB cells induced by the essential oil isolated from Artemisia iwayomogi. , 2009, Journal of ethnopharmacology.

[194]  Y. Yoo,et al.  Anti-invasive activity of sanguinarine through modulation of tight junctions and matrix metalloproteinase activities in MDA-MB-231 human breast carcinoma cells. , 2009, Chemico-biological interactions.

[195]  D. Newman,et al.  Impact of natural products on developing new anti-cancer agents. , 2009, Chemical reviews.

[196]  M. Micallef,et al.  An extract from Ricinus communis L. leaves possesses cytotoxic properties and induces apoptosis in SK-MEL-28 human melanoma cells , 2009, Natural product research.

[197]  K. Straif,et al.  A review of human carcinogens--Part B: biological agents. , 2009, The Lancet. Oncology.

[198]  M. Dietel,et al.  Comparision of the Cytotoxic Effects of Birch Bark Extract, Betulin and Betulinic Acid Towards Human Gastric Carcinoma and Pancreatic Carcinoma Drug-sensitive and Drug-Resistant Cell Lines , 2009, Molecules.

[199]  D. Newman,et al.  Nature: a vital source of leads for anticancer drug development , 2009, Phytochemistry Reviews.

[200]  R. Curi,et al.  Apoptosis induction by 4-nerolidylcatechol in melanoma cell lines. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.

[201]  V. Ooi,et al.  Chemical composition and antiproliferative activity of essential oil from the leaves of a medicinal herb, Schefflera heptaphylla , 2009, Phytotherapy research : PTR.

[202]  R. A. Epifanio,et al.  Organismos marinhos como fonte de novos fármacos: histórico & perspectivas , 2009 .

[203]  A. Edris.  Anti-cancer properties of Nigella spp. essential oils and their major constituents, thymoquinone and beta-elemene. , 2009, Current clinical pharmacology.

[204]  B. Aggarwal,et al.  Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. , 2009, The international journal of biochemistry & cell biology.

[205]  Cecilia Díaz,et al.  Chemical composition of Schinus molle essential oil and its cytotoxic activity on tumour cell lines , 2008, Natural product research.

[206]  John M Lambert,et al.  Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugate. , 2008, Cancer research.

[207]  D. Bentrem,et al.  Apigenin Inhibits the GLUT-1 Glucose Transporter and the Phosphoinositide 3-Kinase/Akt Pathway in Human Pancreatic Cancer Cells , 2008, Pancreas.

[208]  Edward Chu,et al.  A history of cancer chemotherapy. , 2008, Cancer research.

[209]  G. Cragg,et al.  In vitro anticancer screening of South African plants. , 2008, Journal of ethnopharmacology.

[210]  R. Agarwal,et al.  Multitargeted therapy of cancer by silymarin. , 2008, Cancer letters.

[211]  R. Ganju,et al.  Medicinal plants and cancer chemoprevention. , 2008, Current drug metabolism.

[212]  N. Banik,et al.  N-(4-Hydroxyphenyl) retinamide induced both differentiation and apoptosis in human glioblastoma T98G and U87MG cells , 2008, Brain Research.

[213]  M. Jordan,et al.  Inhibition of centromere dynamics by eribulin (E7389) during mitotic metaphase , 2008, Molecular Cancer Therapeutics.

[214]  Tae-Jin Lee,et al.  Sanguinarine‐induced apoptosis: Generation of ROS, down‐regulation of Bcl‐2, c‐FLIP, and synergy with TRAIL , 2008, Journal of cellular biochemistry.

[215]  L. Pistelli,et al.  Essential oils in medicine: principles of therapy. , 2008, Parassitologia.

[216]  Stefan H. E. Kaufmann,et al.  Paul Ehrlich: founder of chemotherapy , 2008, Nature Reviews Drug Discovery.

[217]  A. Tony Kong,et al.  Anticarcinogenesis by dietary phytochemicals: cytoprotection by Nrf2 in normal cells and cytotoxicity by modulation of transcription factors NF-kappa B and AP-1 in abnormal cancer cells. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[218]  Qun-Li Wei,et al.  Apoptosis of human pancreatic cancer cells induced by Triptolide. , 2008, World journal of gastroenterology.

[219]  T. Okada,et al.  MK615 inhibits pancreatic cancer cell growth by dual inhibition of Aurora A and B kinases. , 2008, World journal of gastroenterology.

[220]  H. Ashour.  Antibacterial, antifungal, and anticancer activities of volatile oils and extracts from stems, leaves, and flowers of Eucalyptus sideroxylon and Eucalyptus torquata , 2008, Cancer biology & therapy.

[221]  M. Cascante,et al.  Highly galloylated tannin fractions from witch hazel (Hamamelis virginiana) bark: electron transfer capacity, in vitro antioxidant activity, and effects on skin-related cells. , 2008, Chemical research in toxicology.

[222]  P. Richardson,et al.  A review of lenalidomide in combination with dexamethasone for the treatment of multiple myeloma , 2008, Therapeutics and clinical risk management.

[223]  S. H. Lee,et al.  Enhanced anti-tumor effect of combination therapy with gemcitabine and apigenin in pancreatic cancer. , 2008, Cancer letters.

[224]  M. Shoeb.  Anti-cancer agents from medicinal plants , 2008 .

[225]  N. Amariglio,et al.  Δ9-Tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells , 2008, Acta oncologica.

[226]  E. Hayden,et al.  Cancer complexity slows quest for cure , 2008, Nature.

[227]  S. Hingorani,et al.  EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. , 2008, Frontiers in bioscience : a journal and virtual library.

[228]  V. Cardile,et al.  Eugenol and its synthetic analogues inhibit cell growth of human cancer cells (Part I) , 2008 .

[229]  S. El-Sawi,et al.  Chemical composition, cytotoxic activity and antimicrobial activity of essential oils of leaves and berries of Juniperus phoenicea L. grown in Egypt. , 2008, African journal of traditional, complementary, and alternative medicines : AJTCAM.

[230]  N. Banik,et al.  Retinoids induced astrocytic differentiation with down regulation of telomerase activity and enhanced sensitivity to taxol for apoptosis in human glioblastoma T98G and U87MG cells , 2008, Journal of Neuro-Oncology.

[231]  Shigetoshi Kadota,et al.  Bioactive secondary metabolites from Boesenbergia pandurata of Myanmar and their preferential cytotoxicity against human pancreatic cancer PANC-1 cell line in nutrient-deprived medium. , 2007, Journal of natural products.

[232]  Jiachuan Lei,et al.  Composition, cytotoxicity and antimicrobial activity of essential oil from Dictamnus dasycarpus , 2007 .

[233]  J. Milner,et al.  A review of the interaction among dietary antioxidants and reactive oxygen species. , 2007, The Journal of nutritional biochemistry.

[234]  R. Tundis,et al.  Cytotoxic activity of essential oils from labiatae and lauraceae families against in vitro human tumor models. , 2007, Anticancer research.

[235]  Jai-Sing Yang,et al.  Berberine induces apoptosis in human HSC-3 oral cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway. , 2007, Anticancer research.

[236]  L. Andĕra,et al.  Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts , 2007, Molecular Cancer Therapeutics.

[237]  Shun-Fa Yang,et al.  Elevated expression of NF-κB in oral submucous fibrosis – Evidence for NF-κB induction by safrole in human buccal mucosal fibroblasts , 2007 .

[238]  Woong Nam,et al.  Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells , 2007, Head & neck.

[239]  Paul Tempst,et al.  PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. , 2007, Molecular cell.

[240]  Shun-Fa Yang,et al.  Elevated expression of NF-kappaB in oral submucous fibrosis--evidence for NF-kappaB induction by safrole in human buccal mucosal fibroblasts. , 2007, Oral Oncology.

[241]  R. Gussio,et al.  Comparison of the Activities of the Truncated Halichondrin B Analog NSC 707389 (E7389) with Those of the Parent Compound and a Proposed Binding Site on Tubulin , 2006, Molecular Pharmacology.

[242]  H. Harn,et al.  The natural compound n-butylidenephthalide derived from Angelica sinensis inhibits malignant brain tumor growth in vitro and in vivo3 , 2006, Journal of neurochemistry.

[243]  Rajkapoor Balasubramanian,et al.  Cytotoxic activity of flavone glycoside from the stem of Indigofera aspalathoides Vahl , 2006, Journal of Natural Medicines.

[244]  A. Scheck,et al.  Bmc Complementary and Alternative Medicine Anticancer Activity of Extracts Derived from the Mature Roots of Scutellaria Baicalensis on Human Malignant Brain Tumor Cells , 2006 .

[245]  J. Manosroi,et al.  Anti-proliferative activity of essential oil extracted from Thai medicinal plants on KB and P388 cell lines. , 2006, Cancer letters.

[246]  H. Esumi,et al.  Angelmarin, a novel anti-cancer agent able to eliminate the tolerance of cancer cells to nutrient starvation. , 2006, Bioorganic & medicinal chemistry letters.

[247]  M. Apel,et al.  SCREENING OF THE BIOLOGICAL ACTIVITY FROM ESSENTIAL OILS OF NATIVE SPECIES FROM THE ATLANTIC RAIN FOREST (SÃO PAULO - BRAZIL) , 2006 .

[248]  Marcy J. Balunas,et al.  Drug discovery from medicinal plants. , 2005, Life sciences.

[249]  Sanjeev Banerjee,et al.  Curcumin Suppresses the Paclitaxel-Induced Nuclear Factor-κB Pathway in Breast Cancer Cells and Inhibits Lung Metastasis of Human Breast Cancer in Nude Mice , 2005, Clinical Cancer Research.

[250]  D. Newman,et al.  Plants as a source of anti-cancer agents. , 2005, Journal of ethnopharmacology.

[251]  M. Jordan,et al.  The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growth , 2005, Molecular Cancer Therapeutics.

[252]  H. Harn,et al.  The Antitumor Effects of Angelica sinensis on Malignant Brain Tumors In vitro and In vivo , 2005, Clinical Cancer Research.

[253]  C. Teng,et al.  Antitumor mechanism of evodiamine, a constituent from Chinese herb Evodiae fructus, in human multiple-drug resistant breast cancer NCI/ADR-RES cells in vitro and in vivo. , 2005, Carcinogenesis.

[254]  M. Cascante,et al.  Procyanidin fractions from pine (Pinus pinaster) bark: radical scavenging power in solution, antioxidant activity in emulsion, and antiproliferative effect in melanoma cells. , 2005, Journal of agricultural and food chemistry.

[255]  Frederick W. Alt,et al.  DNA Repair, Genome Stability, and Aging , 2005, Cell.

[256]  A. Jafarian,et al.  Cytotoxic Effects of Essential Oils of Some Iranian Citrus Peels , 2005 .

[257]  Zengli Yu,et al.  Inhibition of proliferation and induction of apoptosis by genistein in colon cancer HT-29 cells. , 2004, Cancer letters.

[258]  M. Poupon,et al.  Geraniol, a component of plant essential oils, modulates DNA synthesis and potentiates 5-fluorouracil efficacy on human colon tumor xenografts. , 2004, Cancer letters.

[259]  N. Seeram,et al.  Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. , 2004, Anticancer research.

[260]  Melvin J. Yu,et al.  Induction of Morphological and Biochemical Apoptosis following Prolonged Mitotic Blockage by Halichondrin B Macrocyclic Ketone Analog E7389 , 2004, Cancer Research.

[261]  P. Crooks,et al.  L-Canavanine as a radiosensitization agent for human pancreatic cancer cells , 2003, Molecular and Cellular Biochemistry.

[262]  J. Crawford,et al.  Activation of tyrosine kinases in cancer. , 2003, The oncologist.

[263]  J. Bocsi,et al.  Mimosine, a plant-derived amino acid induces apoptosis in human pancreatic cancer xenografts. , 2003, Anticancer research.

[264]  Thomas Davis,et al.  Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[265]  A. Redkar,et al.  Resveratrol is a potent inducer of apoptosis in human melanoma cells. , 2003, Cancer letters.

[266]  L. Coussens,et al.  Inflammation and cancer , 2002, Nature.

[267]  J. Pezzuto,et al.  The Chemical Constituents and Biological Activity of Essential Oil of Lavandula stoechas ssp. stoechas , 2002, Zeitschrift fur Naturforschung. C, Journal of biosciences.

[268]  R. Orlowski,et al.  Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. , 2002, Cancer research.

[269]  Takao Yokota,et al.  Plant foods and herbal sources of resveratrol. , 2002, Journal of agricultural and food chemistry.

[270]  L. Fu,et al.  The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells. , 2002, European journal of cancer.

[271]  R. Papac.  Origins of cancer therapy. , 2001, The Yale journal of biology and medicine.

[272]  Q. K. Tran,et al.  New spirostanol steroids and steroidal saponins from roots and rhizomes of Dracaena angustifolia and their antiproliferative activity. , 2001, Journal of natural products.

[273]  Melvin J. Yu,et al.  In vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin B. , 2001, Cancer research.

[274]  G. Freeman,et al.  Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation , 2000, The Journal of experimental medicine.

[275]  H. Verheul,et al.  The Role of Vascular Endothelial Growth Factor (VEGF) in Tumor Angiogenesis and Early Clinical Development of VEGFReceptor Kinase Inhibitors , 2000 .

[276]  G. Schwartsmann,et al.  Anti-cancer drug discovery and development in Brazil: targeted plant collection as a rational strategy to acquire candidate anti-cancer compounds. , 2000, The oncologist.

[277]  Melvin J. Yu,et al.  Structure-activity relationships of halichondrin B analogues: modifications at C.30-C.38. , 2000, Bioorganic & medicinal chemistry letters.

[278]  S. Fujisawa,et al.  Radical generation, radical-scavenging activity, and cytotoxicity of eugenol-related compounds. , 2000, In vitro & molecular toxicology.

[279]  C. Chi,et al.  Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel , 1999, British Journal of Cancer.

[280]  V. Natarajan,et al.  [The Nobel Prize in physiology or medicine]. , 1998, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[281]  V. Dixit,et al.  Proteolysis of poly(ADP-ribose) polymerase by caspase 3: kinetics of cleavage of mono(ADP-ribosyl)ated and DNA-bound substrates. , 1998, Radiation research.

[282]  Y. Kishi,et al.  New Synthetic Route to the C.14—C.38 Segment of Halichondrins. , 1998 .

[283]  Y. Kishi,et al.  New Synthetic Route to the C.14−C.38 Segment of Halichondrins , 1997 .

[284]  D. Kufe,et al.  Caspase-3-mediated Cleavage of Protein Kinase C θ in Induction of Apoptosis* , 1997, The Journal of Biological Chemistry.

[285]  B. Foster,et al.  Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[286]  J. Allison,et al.  Enhancement of Antitumor Immunity by CTLA-4 Blockade , 1996, Science.

[287]  J. Jeng,et al.  Eugenol Triggers Different Pathobiological Effects on Human Oral Mucosal Fibroblasts 1 , 1994, Journal of dental research.

[288]  M. Pike,et al.  Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. , 1993, Epidemiologic reviews.

[289]  Craig J. Forsyth,et al.  Total synthesis of halichondrin B and norhalichondrin B , 1992 .

[290]  K D Paull,et al.  Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data. , 1991, The Journal of biological chemistry.

[291]  R. Noble.  The discovery of the vinca alkaloids--chemotherapeutic agents against cancer. , 1990, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[292]  V. Cody,et al.  Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. , 1989, Biochemical pharmacology.

[293]  D. Uemura,et al.  Halichondrins - antitumor polyether macrolides from a marine sponge , 1986 .

[294]  I. S. Johnson,et al.  THE VINCA ALKALOIDS: A NEW CLASS OF ONCOLYTIC AGENTS. , 1963, Cancer research.

[295]  J DOBSON,et al.  John Hunter's views on cancer. , 1959, Annals of the Royal College of Surgeons of England.

[296]  R L NOBLE,et al.  ROLE OF CHANCE OBSERVATIONS IN CHEMOTHERAPY: VINCA ROSEA * , 1958, Annals of the New York Academy of Sciences.

[297]  C. Dolea,et al.  World Health Organization , 1949, International Organization.